Raclopride studies of dopamine release: Dependence on presynaptic integrity

Biological Psychiatry

Volumn 54, Issue 11, 2003, Pages 1193-1199

  Doudet, Doris J ^a,c   Holden, James E ^b  

^a TRIUMF   (Canada)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Amphetamine; D 2 receptors; Dopamine release; Positron emission tomography; Raclopride; Receptor affinity

Indexed keywords

DOPAMINE; DOPAMINE 2 RECEPTOR; LIGAND; METHAMPHETAMINE; RACLOPRIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN INJURY; CONTROLLED STUDY; DOPAMINE RELEASE; DRUG RECEPTOR BINDING; NERVE ENDING; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PRESYNAPTIC NERVE; PRIORITY JOURNAL; PROTEIN DETERMINATION; RECEPTOR AFFINITY; RECEPTOR BINDING; RECEPTOR DENSITY; RHESUS MONKEY; SCHIZOPHRENIA;

EID: 0344430080     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(03)00288-9     Document Type: Article

References (31)

1. Breier A., Su T.P., Saunders R.C., Carson R.E., Kolachana B.S., de Bartolomeis A., et al. Schizophrenia is associated with elevated amphetamine-induced dopamine concentrations Evidence from a novel positron emission tomography method . Proc Natl Acad Sci U S A. 94:1997;2569-2574.
2. Butcher S.P., Fairbrother I.S., Kelley J.S., Arbuthnott G.W. Amphetamine-induced dopamine release in the rat striatum An vivo microdialysis study . J Neurochem. 50:1988;346-355.
3. Carson R.E., Channing M.A., Der M.G., Herscovitch P., Eckelman W.C. Scatchard analysis with bolus/infusion administration of [C-11]raclopride Amphetamine effects in anesthetized monkeys . Senda M., Kimura Y., Herscovitch P. Brain Imaging Using PET. 2002;63-69 Academic Press, San Diego, CA.
4. 11C]raclopride in anesthetized monkeys . Gjedde A. Molecular and Pharmacologic Brain Imaging with Positron Emission Tomography. 2000;205-209 Academic Press, San Diego, CA.
5. 3H] spiperone binding Evidence for accumulation in corpus striatum by agonist-mediated receptor internalization . J Cereb Blood Flow Metab. 8:1998;291-303.
6. 11C-raclopride is altered by drugs that modify synaptic dopamine levels. Synapse. 13:1993;350-356.
7. Doudet D.J. PET studies in the MPTP model of Parkinson's disease. Calne D.B., Calne S. Parkinson's Disease Advances in Neurology . Volume 86:2000;187-195 Lippincott Williams & Wilkins, Philadelphia.
8. 18F]Fluoro-L-DOPA PET studies of the turnover of dopamine in MPTP-induced parkinsonism in monkeys. Synapse. 29:1998;225-232.
9. 11C] raclopride. Application to amphetamine effects . NeuroImage. 16:2002;S50.
10. Doudet D.J., Holden J.E., Jivan S., McGeer E.G., Wyatt R.J. In vivo PET studies of the dopamine D2 receptors in rhesus monkeys with long-term MPTP-induced parkinsonism. Synapse. 38:2000;105-113.
11. 11C[raclopride . NeuroImage. 11:(6):2000;S5.
12. 11C]raclopride . Synapse. 44:2002;198-202.
13. 11C]raclopride Combined PET-microdialysis studies . J Cereb Blood Flow Metab. 17:1997;932-942.
14. 2 dopamine receptor binding in the living human brain by PET. Science. 231:1986;258-261.
15. Ginovart N., Farde L., Halldin C., Swahn C.G. Changes in striatal D2-receptor density following chronic treatment with amphetamine as assessed with PET in nonhuman primates. Synapse. 31:1999;154-162.
16. 3H] raclopride to rat and human brain membranes. J Neurochem. 55:1990;2048-2057.
17. Holden J.E., Jivan S., Ruth T.J., Doudet D.J. In vivo receptor assay with multiple ligand concentrations An equilibrium approach . J Cereb Blood Flow Metab. 22:2002;1132-1141.
18. Jones S.R., Gainetdinov R.R., Wightman R.M., Caron M.G. Mechanisms of amphetamine action revealed in mice lacking the dopamine transporter. J Neurosci. 18:1998;1979-1986.
19. Koepp M.J., Gunn R.N., Lawrence A.D., Cunningham V.J., Dagher A., Jones T., et al. Evidence for striatal dopamine release during a video game. Nature. 393:1998;266-268.
20. Kuczenski R., Segal D. Concomitant characterization of behavioral and striatal neurotransmitter response to amphetamine using in vivo microdialysis. J Neurosci. 9:1989;2051-2065.
21. Laruelle M. Imaging synaptic neurotransmission with in vivo binding competition techniques A critical review . J Cereb Blood Flow Metab. 20:2000;423-452.
22. Laruelle M. The role of endogenous sensitization in the pathophysiology of schizophrenia Implications from recent brain imaging studies . Brain Res Rev. 31:2000;371-384.
23. Laruelle M., Abi-Dargham A., Van Dick C.H., Gil R., D'Souza C.D., Erdos J., et al. Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects. Proc Natl Acad Sci U S A. 93:1996;9235-9240.
24. Laruelle M., Iyer R.N., Al-Tikriti M.S., Zea-Ponce Y., Malison R.T., Zoghbi S.S., et al. Microdialysis and SPECT measurements of amphetamine-induced dopamine release in non-human primates. Synapse. 25:1997;1-14.
25. Logan J., Fowler J.S., Volkow N.D., Wang G.J., Ding Y.S., Alexoff D.L. Distribution volume ratios without blood sampling from graphical analysis of PET data. J Cereb Blood Flow Metab. 16:1996;834-840.
26. Piccini P., Brooks D.J., Bjorklund A., Gunn R.N., Grasby P.M., Rimoldi O., et al. Dopamine release from nigral transplants visualized in vivo in a Parkinson's patient. Nature Neurosci. 12:1999;1047-1140.
27. Scatchard G. The attractions of proteins for small molecules and ions. Ann N Y Acad Sci. 51:1949;660-672.
28. Sibley D.R., Creese I. Pseudo non-competitive interactions with dopamine receptors. Eur J Pharmacol. 65:1980;131-133.
29. 11C]raclopride displacement and PET. Neurology. 46:1996;1430-1436.
30. Tsukada H., Nishiyama S., Kakiuchi T., Hiroyuki O., Sato K., Harada N., et al. Isoflurane anesthesia enhances the inhibitory effects of cocaine and GBR12909 on dopamine transporter PET studies in combination with microdialysis in the monkey brain . Brain Res. 849:1999;85-96.
31. 11C]raclopride? PET studies combined with microdialysis in conscious monkeys . Brain Res. 841:1999;160-169.